SCHEMBL6170489

SCHEMBL6170489

O=C(c1ccccc1)c1cc2cc(Cl)c(Cl)cc2[nH]1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.70
KMT2A Q03164 3/20 0.70
NPC1 O15118 2/20 0.70
RAB9A P51151 2/20 0.70
HDAC6 Q9UBN7 2/20 0.57
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2C9 P11712 1/20 0.57
TSHR P16473 1/20 0.57
ALOX15 P16050 2/20 0.52
FLT3 P36888 3/20 0.50
HDAC3 O15379 1/20 0.50
HDAC4 P56524 1/20 0.50
HDAC1 Q13547 1/20 0.50
HDAC7 Q8WUI4 1/20 0.50
HDAC2 Q92769 1/20 0.50
HDAC10 Q969S8 1/20 0.50
HDAC11 Q96DB2 1/20 0.50
HDAC8 Q9BY41 1/20 0.50
HDAC9 Q9UKV0 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6170605 0.83 MEN1 (0.78) MEN1KMT2ANPC1RAB9AHDAC6
SCHEMBL2729915 0.80 FLT3 (0.79) MEN1KMT2ANPC1RAB9AHDAC6
SCHEMBL3641952 0.79 GPR35 (0.63) MEN1KMT2ACYP1A2CYP2C9TSHR
SCHEMBL4268891 0.79 MEN1 (0.63) MEN1KMT2ANPC1RAB9AHDAC6
SCHEMBL8622921 0.78 GPR35 (0.61) MEN1KMT2ACYP1A2CYP2C9TSHR
SCHEMBL6168641 0.76 FLT3 (0.60) MEN1KMT2ANPC1RAB9AHDAC6
SCHEMBL6171590 0.76 MEN1 (0.56) MEN1KMT2ANPC1RAB9AHDAC6
SCHEMBL11002795 0.76 MEN1 (0.55) MEN1KMT2ANPC1RAB9AHDAC6
SCHEMBL5716697 0.76 RAB9A (0.56) MEN1KMT2ANPC1RAB9AHDAC6
SCHEMBL6168680 0.75 MEN1 (0.58) MEN1KMT2ANPC1RAB9AHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1045833-B1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER (US) 2005-11-02 EP disclosed
US-6608070-B1 Useful for treatment of medical condition in which prostaglandins are implicated as pathogens NAKAO KAZUNARI (JP) 2003-08-19 US disclosed
EP-1045833-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER INC. (US) 2000-10-25 EP disclosed
WO-1999035130-A1 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS PFIZER PHARMACEUTICALS INC. (JP) 1999-07-15 WO disclosed